A new paper by a team of Concordia researchers from the departments of Biology and Physics proposes a novel method of ...

Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double digits.

The process begins when cancer cells release protein fragments, or antigens, that are captured by APCs. These cells present the antigens to T cells, effectively "priming" them to recognize cancer ...

Ultrasound-directed microbubbles could be used to influence the behavior of cancer-fighting T cells, reinvigorating the ...

UNC Lineberger Comprehensive Cancer Center researchers have discovered a three-drug combination that enhances the generation ...

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets the immune checkpoint B7-H3 for diffuse intrinsic pontine glioma, or DIPG, ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...